Rivalry - RVLCF STOCK NEWS

Rivalry Corp (TSXV: RVLY) (OTCQX: RVLCF) has announced the integration of $TRUMP, Donald Trump's official Solana cryptocurrency, as a new payment method on its platform. The implementation comes less than 24 hours after the cryptocurrency's release and ahead of the U.S. Presidential Inauguration on January 20th, 2025.

The $TRUMP token, currently valued at over USD $30 billion in fully diluted terms, will be available for deposits and wagering in jurisdictions under the Company's Isle of Man license. As part of the launch, Rivalry is offering special rewards through February 1, 2025, including a 20x multiplier on NUTZ (Rivalry's native token) earnings for users betting with $TRUMP.

This addition aligns with Rivalry's crypto-first approach, maintaining treasury holdings of various major cryptocurrencies and meme coins accepted on their platform. The company plans to continue expanding its cryptocurrency payment options to support its player base and growth in the crypto gambling segment.

Rivalry Corp. (TSXV: RVLY) (OTCQX: RVLCF) has completed its non-brokered private placement of units at $0.15 per unit. The company issued a total of 22,146,851 units, raising aggregate gross proceeds of approximately $3.32 million. The funds will be allocated towards corporate development and general working capital purposes.

Rivalry Corp (TSXV: RVLY) (OTCQX: RVLCF) has completed the third tranche of its non-brokered private placement, raising $334,688 through the issuance of 2,231,253 Units at $0.15 per Unit. Each Unit consists of one subordinate voting share and half a warrant, with each whole warrant exercisable at $0.25 for 12 months.

The company may conduct additional closings to reach aggregate proceeds of up to USD$3 million. The proceeds will be used for corporate development and working capital. The securities are subject to a four-month hold period. The company paid $10,501.20 in finder's fees for this tranche.

Notable related party transactions included 100,200 Units issued to family members of director Steven Isenberg and 500,000 Units to director Kevin Wimer.

Rivalry Corp (RVLCF) reported Q3 2024 results with betting handle of $79.9M and adjusted revenue of $6.0M, including $3.0M in deferred revenue from Rivalry Token (NUTZ). The company completed a major organizational realignment, reducing operating expenses by approximately 50% and headcount by 50%. Average net revenue per user increased by 51% compared to 2024 YTD average and 70% versus three-year trailing average.

The company executed its largest product overhaul, implementing a crypto-first strategy. Crypto wallet-connected customers generate 200% more revenue than baseline users, with 30% higher retention rates. Rivalry closed a second tranche of non-brokered private placement for $1.0M, bringing total proceeds to $3.0M.

Rivalry Corp (TSXV: RVLY) (OTCQX: RVLCF) has completed the initial tranche of a non-brokered private placement, raising approximately $1.94 million through the issuance of 12,930,707 units at $0.15 per unit. Each unit includes one subordinate voting share and half a warrant, with each full warrant exercisable at $0.25 for 12 months. The company may raise up to USD$3 million through additional closings. The initial tranche was primarily subscribed by insiders, family, friends, and long-term shareholders. Proceeds will be used for corporate development and working capital. The securities are subject to a four-month hold period.

Rivalry Corp. (TSXV: RVLY) (OTCQX: RVLCF), a leading sportsbook and iGaming operator focused on Gen Z, has announced the upcoming release of its Q3 2024 financial results. The results will be published on November 29, 2024, before trading begins on the TSX Venture Exchange. Management will host an investor conference call at 10:00 am EDT on the same day to discuss the results. The call will be accessible via toll-free number 1-800-717-1738 or international number (+1) 289-514-5100, with a live webcast available through the company's website.

Rivalry Corp. (TSXV: RVLY) (OTCQX: RVLCF) reported Q2 2024 results, highlighting $87.8 million in betting handle and $4.7 million in net revenue, up 22% year-over-year. The company achieved a record net revenue margin of 62.5%, demonstrating successful margin growth efforts. Rivalry Token, launched in May 2024, has driven $1.7 million in additional revenue post-quarter, accelerating crypto expansion efforts. The token is attracting high-value players, with token customers exhibiting twice the value of average non-crypto users. Rivalry is shifting focus to crypto expansion and VIP players, aiming to drive growth while maintaining current operational expense levels. The company maintains its H2 2024 profitability guidance.

Rivalry Corp. (TSXV: RVLY) (OTCQX: RVLCF), a leading sportsbook and iGaming operator for Gen Z, has announced it will release its Q2 2024 financial results on August 29, 2024, before market open. The company will host an investor conference call at 10:00 am EDT on the same day to discuss the results.

Additionally, Rivalry has announced a management change. Demi Abidogun-Benson will assume the role of Interim Chief Financial Officer effective August 16, 2024, replacing Kejda Qorri. Abidogun-Benson, who joined Rivalry in February 2022, brings over a decade of experience in corporate reporting, auditing, and strategic planning.

Rivalry Corp, a leading sportsbook and iGaming operator focused on Gen Z, announced that its Co-founder and CEO, Steven Salz, will present at the Canadian Gaming Summit in Toronto on June 20, 2024. Salz is scheduled to participate in a panel discussion at 11:45 am, titled “Next-Gen gamification: engaging Millennials and Gen Z.” This panel will delve into gamification strategies aimed at capturing the next generation of bettors through methods such as social gaming, loyalty programs, and interactive storytelling. The Canadian Gaming Summit is a key annual event for gaming and sports betting executives, expected to draw 2,000 delegates from various industries including casino, sports betting, payments, technology, and investment.